Stock ODT ODONATE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Odonate, Inc.

Equities

ODT

US6760793041

Delayed OTC Markets
Other stock markets
 02:05:58 2024-04-16 pm EDT 		5-day change 1st Jan Change
15,900 USD +2.45% Intraday chart for Odonate, Inc. +2.45% +6.00%
2023 North American Morning Briefing : Recession Threat Grows as Further Tightening Likely DJ
2023 North American Morning Briefing : Stock Futures -2- DJ

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Odonate Therapeutics Gets Nasdaq Notice to Delist Shares
Insider Sell: Odonate Therapeutics
Odonate Therapeutics Plans Share Buybacks After Halting Development of Breast Cancer Drug
Odonate Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Odonate Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Odonate Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
Odonate Therapeutics : Stock Slumps on Plans to Scrap Cancer Drug Tesetaxel Development
Midday Report: Wall Street Rises Midday as Data Cool Inflation Worries
Sector Update: Health Care Stocks Rising Just Ahead of Monday Close
Sector Update: Health Care Stocks Posting Modest Gains
Odonate Therapeutics : to Discontinue Development of Tesetaxel for Cancer; Shares Plunge
Odonate Therapeutics : Posts Narrower Q4 Loss
Odonate Therapeutics : Insiders Make Significant Stock Buys in Odonate Therapeutics (ODT) Shares Extending the 90 day Trend
Odonate Therapeutics : Tang Capital Ups Stake in Odonate Therapeutics to 41.6%
Odonate Therapeutics : Insider buy at Odonate Therapeutics (ODT) Extends the Trend of purchases over Last Quarter
Odonate Therapeutics : Announces Positive Results From Phase 3 Trial of Tesetaxel in Metastatic Breast Cancer Patients
Odonate Therapeutics : Files Shelf for up to $150 Million in Common Shares
Odonate Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Odonate Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ODT Stock
  4. News Odonate, Inc.
  5. Other languages